EP2790718

ANTAGONIST OF THE FIBROBLAST GROWTH FACTOR RECEPTOR 3 (FGFR3) FOR USE IN THE TREATMENT OR THE PREVENTION OF SKELETAL DISORDERS LINKED WITH ABNORMAL ACTIVATION OF FGFR3

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    12.12.2012
  • EP published:
    7.2.2018
  • EP application number:
    12799204.8
  • Max expiry date:
    11.12.2032
  • Title:
    ANTAGONIST OF THE FIBROBLAST GROWTH FACTOR RECEPTOR 3 (FGFR3) FOR USE IN THE TREATMENT OR THE PREVENTION OF SKELETAL DISORDERS LINKED WITH ABNORMAL ACTIVATION OF FGFR3

Timeline

Today
12.12.2012EP application
7.2.2018EP Publication

Owner

  • Name:
    Institut National de la Santé et de la Recherche Médicale (INSERM)
  • Address:
    101, rue de Tolbiac, 75013, Paris, FR
  • Name:
    Université Paris Descartes
  • Address:
    12, rue de l'Ecole de Médecine, 75006, Paris, FR
  • Name:
    Centre National de la Recherche Scientifique (C.N.R.S.)
  • Address:
    3, rue Michel-Ange, 75016, Paris, FR
  • Name:
    Assistance Publique Hôpitaux de Paris
  • Address:
    3 Avenue Victoria, 75004, Paris, FR
  • Name:
    Université Paris Diderot - Paris 7
  • Address:
    5, rue Thomas Mann, 75013, Paris, FR
  • Name:
    Imagine
  • Address:
    24, Boulevard du Montparnasse, 75015, Paris, FR

Inventor

  • Name:
    LEGEAI-MALLET, Laurence
  • Address:
    Paris, FR
  • Name:
    MUNNICH, Arnold
  • Address:
    PARIS, FR
  • Name:
    BUSCA, Patricia
  • Address:
    PARIS, FR
  • Name:
    BARBAULT, Florent
  • Address:
    75205 PARIS Cedex 13, FR

Priority

  • Number:
    PCT/IB2011/003253
  • Date:
    12.12.2011
  • Country:
    WO

Classification

  • Categories:
    A61K 38/17, A61K 31/519, A61P 19/00, A61K 31/506

Upload documents